Following Eli Lilly, drugmaker Novo Nordisk announces cuts to insulin prices

Novo Nordisk will lower its insulin list prices by up to 75% in the U.S. Insulin costs in the U.S. are higher than other parts of the world. The move follows Eli Lilly's earlier decision to lower costs.